Visceral extra‐abdominal panniculitis after COVID19

“Retractile mesenteritis” was the first name given to a rare, benign, inflammatory disease that affects the adipose tissue of the intestinal mesentery and less frequently other locations. Now labeled as mesenteric panniculitis, the pathogenic mechanism remains unclear. Several stimuli could be invol...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of rheumatic diseases Vol. 26; no. 4; pp. 793 - 796
Main Authors Ausín‐García, Cristina, Cervilla‐Muñoz, Eva, Demelo‐Rodríguez, Pablo, Villalba‐García, María Victoria, Alvarez‐Sala Walther, Luis A.
Format Journal Article
LanguageEnglish
Published England Wiley Subscription Services, Inc 01.04.2023
Subjects
Adipose tissue
Autoimmune diseases
biopsy
corticosteroids
COVID-19
COVID-19 - complications
COVID19
Diagnosis, Differential
Humans
inflammation
Inflammatory diseases
Malignancy
Mesentery
panniculitis
Panniculitis - diagnosis
Panniculitis - etiology
Panniculitis, Peritoneal - diagnostic imaging
Panniculitis, Peritoneal - drug therapy
postCOVID19
RNA, Viral
SARS-CoV-2
panniculitis
COVID19
corticosteroids
malignancy
inflammation
postCOVID19
biopsy
Online AccessGet full text

Cover

More Information
Summary:“Retractile mesenteritis” was the first name given to a rare, benign, inflammatory disease that affects the adipose tissue of the intestinal mesentery and less frequently other locations. Now labeled as mesenteric panniculitis, the pathogenic mechanism remains unclear. Several stimuli could be involved, and it is sometimes associated with other conditions such as malignancy or autoimmune diseases. We present a case of mesenteric panniculitis with extensive abdominal and extra‐abdominal involvement that developed a few months after SARS‐COV2 infection, raising the hypothesis of this virus as a potential trigger for autoinflammatory and autoimmune diseases.
ISSN:1756-1841
1756-185X
DOI:10.1111/1756-185X.14544